• Last Updated 16:00:00 May 24, 2016

Start Guide
MENU

KEY DRIVERS Get Embed Code

Global Innovative Pharmaceutical Sales$3.64 B
Global Established Pharmaceutical Sales$5.97 B
Total Revenue$13 B

SIGNUP FOR BETA ACCESS

TO UNLOCK KEY DRIVERS

OPERATING SALES

SIGNUP FOR BETA ACCESS

TO UNLOCK FULL SEGMENT DATA

Trading Metrics Get Embed Code

50-Day Moving Average $32.17
200-Day Moving Average $32.16
Average Daily Volume (30-Day) 56.5 M
Market Beta 0.84
Year-to-Date Price Change 5.6%
1-Year Price Change -0.0%
Short Interest 2%
Days to Cover 1.9

Metrics

Drugs Portfolio202
Pipeline Projects93
Therapeutic Areas39
Prevnar$1.51 B
Lyrica$1.01 B
Enbrel$733 M

DEBT & Liquidity

$39.4 B Total Debt

$2.56 B Total Cash

62.2% Debt/Equity

24.2% Debt/Assets

Summary

PFE

Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following segments: Global Innovative... +

235 East 42nd Street
New York New York

Website | Map

CEO

Ian C. Read

Founded in

1849

Employees

97,900

Revenue/Employee

$0.52 m

IPO Date

June 22, 1942

Fiscal Year Ends

FY16 - Dec 31, 2016

Sector

Healthcare

Industry

Pharmaceuticals

QUARTERLY
Revenue$13 B
Revenue Growth0
EPS$0.49
EPS Growth29%

SIGNUP FOR BETA ACCESS

TO UNLOCK ANNUAL DATA

1.44 Current Ratio

0.09 Cash Ratio

1.83% ROAA

4.72% ROAE

29.7% Operating Margin

81.1% Gross Margin

23.3% Net Income Margin

29% EPS Growth

Dividends & Splits

$0.3 Dividend Per Share

3.52% Dividend Yield

100.6% Payout Ratio

2016-02-03 Ex-Dividend Date

VALUATION PEERS Get Embed Code

  • Company

  • Change

  • P/E

  • P/S

  • P/BOOK

  • EV

  • PFE

  • +1.3%

  • 25.3

  • 3.7

  • 3.3

  • $207 B

  • AGN

  • +1.5%

  • NA

  • NA

  • NA

  • NA

  • MRK

  • +1.2%

  • NA

  • NA

  • NA

  • NA

  • JNJ

  • +0.5%

  • NA

  • NA

  • NA

  • NA

OUR DATA PARTNERS

  • MARKET DATA PROVIDED BY

  • FUNDAMENTALS AND METRICS COMPILED BY

  • CHARTING APIs PROVIDED BY

  • EARNINGS ESTIMATES VIA